Pharmacokinetics of nelfinavir in HIV‐1‐infected pregnant and nonpregnant women - Concepedia

Concepedia

Publication | Open Access

Pharmacokinetics of nelfinavir in HIV‐1‐infected pregnant and nonpregnant women

DOI Full Paper Access

65

Citations

16

References

2006

Year

P. Villani, Marco Floridia, Maria Franca Pirillo, Maria Cusato, Enrica Tamburrini, Anna Franca Cavaliere, Giovanni Guaraldi, C. Vanzini, A. Molinari, Anna Degli Antoni,

British Journal of Clinical Pharmacology

Abstract

Our results indicate that women in the later stages of pregnancy may be exposed to subtherapeutic concentrations of NFV. Thus, adjustments in drug dosage or frequency of administration may be required.

References

	Year	Citations
Combination Antiretroviral Strategies for the Treatment of Pregnant HIV-1–Infected Women and Prevention of Perinatal HIV-1 Transmission Ellen Cooper, Manhattan Charurat, Lynne Mofenson, JAIDS Journal of Acquired Immune Deficiency Syndromes	2002	895
Combination Antiretroviral Strategies for the Treatment of Pregnant HIV-1–Infected Women and Prevention of Perinatal HIV-1 Transmission Ellen Cooper, Manhattan Charurat, Lynne Mofenson, JAIDS Journal of Acquired Immune Deficiency Syndromes GynecologyMaternal ImmunizationContraceptionHiv/aids CounsellingHuman Retrovirus	2002	692
HIV-infected pregnant women and vertical transmission in Europe since 1986 European Collaborative Study AIDS Heterosexual AcquisitionReproductive HealthGynecologyInfected Pregnant WomenHigh-risk Pregnancy	2001	160
Therapeutic drug monitoring of nelfinavir and indinavir in treatment-naive HIV-1-infected individuals David M. Burger, Patricia W. H. Hugen, Peter Reiss, AIDS	2003	147
Pregnancy and use of oral contraceptives reduces the biotransformation of proguanil to cycloguanil Rose McGready, Kasia Stepniewska, E.D. Seaton, European Journal of Clinical Pharmacology Hormonal ContraceptiveFertilityOral ContraceptivesOral ContraceptiveMedicine	2003	133
Circulating Metabolites of the Human Immunodeficiency Virus Protease Inhibitor Nelfinavir in Humans: Structural Identification, Levels in Plasma, and Antiviral Activities Kanyin E. Zhang, Amy K. Patick, Bradley M. Kerr, Antimicrobial Agents and Chemotherapy Pharmaceutical ScienceImmunologyPharmacotherapyAntiviral DrugNelfinavir Mesylate	2001	121
Transplacental passage of protease inhibitors at delivery Catia Marzolini, Christoph Rudin, Laurent A. Décosterd, AIDS	2002	115
Pharmacokinetic Basis for Drug Treatment Peter H. Slugg Therapeutic Drug Monitoring Therapeutic Drug MonitoringPharmacodynamicsMedicinePharmacokinetic BasisPharmacology	1984	100
Pharmacokinetics of Saquinavir plus Low-Dose Ritonavir in Human Immunodeficiency Virus-Infected Pregnant Women Edward P. Acosta, Arlene Bardeguez, Carmen Zorrilla, Antimicrobial Agents and Chemotherapy Protease InhibitorsPk Evaluations PostpartumNeurovirologyPharmacologyAntiviral Drug Development	2004	87
The pharmacokinetics of nelfinavir and M8 during pregnancy and post partum Rolf P. G. van Heeswijk, Yasmin Khaliq, Keith Gallicano, Clinical Pharmacology & Therapeutics	2004	69

Page 1